Dyne Therapeutics, Inc. Common Stock (DYN) is a publicly traded Healthcare sector company. As of July 21, 2026, DYN trades at $24.15 with a market cap of $3.92B and a P/E ratio of -6.84. DYN moved +2.86% today. Year to date, DYN is +22.14%; over the trailing twelve months it is +159.98%. Its 52-week range spans $6.36 to $31.32. Analyst consensus is strong buy with an average price target of $40.33. Rallies surfaces DYN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for DYN shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $24.15 |
| Market Cap | $3.92B |
| P/E Ratio | -6.84 |
| EPS | $-3.47 |
| Dividend Yield | 0.00% |
| 52-Week High | $31.32 |
| 52-Week Low | $6.36 |
| Volume | 318.39K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-446.21M |
| Gross Margin | 0.00% |
10 analysts cover DYN: 0 strong buy, 9 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $40.33.